Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@vines2001] |-----------|-------| | Gene Symbol | CLN8 | | Gene Name | Ceroid Lipofuscinosis, Neuronal 8 | | Official Full Name | CLN8, ER Storage Membrane Protein | | Chromosomal Location | 8p23.2 | | GRCh38 Coordinates | chr8:1,723,247-1,755,442 | | NCBI Gene ID | 2055 | | OMIM ID | 607897 | | Ensembl ID | ENSG00000154164 | | UniProt ID | Q9UHD2 | | Gene Family | CLN8 family, ER membrane proteins |
</div>}
Overview
The CLN8 gene encodes an endoplasmic reticulum (ER) membrane protein that plays a critical role in ER-to-lysosome trafficking and lipid metabolism. CLN8 forms a functional complex with CLN6 to mediate the transport of lysosomal enzymes and other cargo. Mutations in CLN8 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including the Turkish variant (late infantile) and Northern Epilepsy (progressive epilepsy with dementia)<sup>[1]</sup>.
Function
Protein Structure
CLN8 is a 286-amino acid transmembrane protein (32 kDa) localized to the ER membrane. It contains multiple transmembrane domains and cytosolic loops<sup>[2]</sup>.
Normal Physiological Roles
...
CLN8 Gene
Introduction
Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@vines2001] |-----------|-------| | Gene Symbol | CLN8 | | Gene Name | Ceroid Lipofuscinosis, Neuronal 8 | | Official Full Name | CLN8, ER Storage Membrane Protein | | Chromosomal Location | 8p23.2 | | GRCh38 Coordinates | chr8:1,723,247-1,755,442 | | NCBI Gene ID | 2055 | | OMIM ID | 607897 | | Ensembl ID | ENSG00000154164 | | UniProt ID | Q9UHD2 | | Gene Family | CLN8 family, ER membrane proteins |
</div>}
Overview
The CLN8 gene encodes an endoplasmic reticulum (ER) membrane protein that plays a critical role in ER-to-lysosome trafficking and lipid metabolism. CLN8 forms a functional complex with CLN6 to mediate the transport of lysosomal enzymes and other cargo. Mutations in CLN8 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including the Turkish variant (late infantile) and Northern Epilepsy (progressive epilepsy with dementia)<sup>[1]</sup>.
Function
Protein Structure
CLN8 is a 286-amino acid transmembrane protein (32 kDa) localized to the ER membrane. It contains multiple transmembrane domains and cytosolic loops<sup>[2]</sup>.
Normal Physiological Roles
ER-Lysosome Trafficking: Mediates protein transport from ER to lysosomes
Lysosomal Enzyme Trafficking: Regulates trafficking of soluble lysosomal enzymes
Lipid Metabolism: Involved in ceramide and fatty acid homeostasis
[Autophagy](/entities/autophagy): Participates in autophagic pathways
Neuronal Function: Essential for neuronal survival
Molecular Interactions
CLN8 interacts with:
CLN6 - ER-lysosomal trafficking complex
COPII machinery - ER export
Lysosomal enzymes - Trafficking partners
ER quality control - Chaperone interactions
Disease Associations
CLN8 Disease (Variant Late Infantile NCL - Turkish Variant)
CLN8 mutations cause classic late infantile NCL in Turkish families<sup>[1]</sup>:
| Feature | Onset | Progression | |---------|-------|-------------| | Seizures | 3-7 years | Myoclonic, generalized | | Vision loss | 4-8 years | Progressive | | Cognitive decline | 4-8 years | Progressive dementia | | Motor dysfunction | 5-10 years | Ataxia, spasticity | | Death | 10-20 years | Variable |
Northern Epilepsy (NE)
A specific CLN8 mutation (c.70C>G, p.R24G) causes Northern Epilepsy, found in Finnish families<sup>[3]</sup>:
| Feature | Onset | Progression | |---------|-------|-------------| | Seizures | 5-10 years | Progressive | | Cognitive decline | 10-20 years | Progressive dementia | | Motor dysfunction | 15-25 years | Ataxia | | Vision loss | Variable | Less prominent | | Death | 30-50 years | Variable |
Common Mutations
| Mutation | Type | Effect | Disease | |----------|------|--------|---------| | c.70C>G (p.R24G) | Missense | Partial function | Northern Epilepsy | | c.301G>A (p.G101S) | Missense | Severe loss | Turkish variant | | c.1165G>A (p.E389K) | Missense | Severe loss | Late infantile | | c.1253A>G (p.Y418C) | Missense | Severe loss | Late infantile | | c.451dupC | Frameshift | Null | Late infantile |
Genotype-Phenotype Correlations
p.R24G homozygous: Northern Epilepsy (milder)
Severe missense/Null: Classic late infantile NCL
Compound heterozygous: Variable
Expression Patterns
Tissue Distribution: High in brain ([cortex](/brain-regions/cortex), cerebellum), retina
Brain Regions: Predominant in [neurons](/entities/neurons)
Cellular Localization: ER membrane
Developmental Expression: Throughout development
Transcript: 1.9 kb mRNA, 4 exons
Therapeutic Approaches
Current Treatments
Anticonvulsants: Seizure management
Supportive care: Multidisciplinary approach
Physical/occupational therapy: Maintain function
Experimental Therapies
Gene therapy: AAV-vector approaches in development
Small molecule approaches: Being investigated
Enzyme replacement: Challenging due to ER localization
Research Directions
Understanding CLN8 function in ER-lysosome trafficking
Developing gene therapy approaches
Characterizing the CLN6-CLN8 complex
Identifying therapeutic targets
Background
The study of Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ranta S, et al, "The neuronal ceroid lipofuscinosis CLN8 protein is associated with endoplasmic reticulum." Neurobiol Dis (2004)
Lonka L, et al, "The localization of the neuronal ceroid lipofuscinosis proteins, CLN5 and CLN8, in the endoplasmic reticulum." Mol Cell Neurosci (2004)
Hirvasniemi A, et al, "Northern epilepsy: a novel form of neuronal ceroid lipofuscinosis." Brain Pathol (2006)
Vines DJ, et al, "Molecular genetics of the neuronal ceroid lipofuscinoses." Brain Res Bull (2001)